Align Technology INC: management transactions · United States · SEC (Form 4)

About Align Technology INC

Align Technology Inc. (ticker ALGN) is a U.S.-listed company traded on the NASDAQ, and for equity investors it is best understood as a global dental medtech platform rather than a pure orthodontics supplier. The company was founded in March 1997 and incorporated in Delaware in April 1997. It pioneered the invisible orthodontics category with Invisalign and later broadened its offering into digital dentistry through iTero intraoral scanners and exocad CAD/CAM software. Its global headquarters are in Tempe, Arizona, while major innovation and commercial functions have historically been anchored in San Jose, California, alongside regional operations in Europe and Asia-Pacific. In that sense, Align combines a U.S. corporate base with a highly international operating footprint. Align’s business is organized around two core segments: Clear Aligner, centered on Invisalign, and Scanners and CAD/CAM Services, which includes iTero and exocad. This structure gives the company exposure to the full digital treatment workflow: digital impression capture, treatment planning, aligner fabrication, and restorative dentistry software and services. Align markets its solutions to orthodontists, general dentists, and laboratories, and management has consistently framed the opportunity as a broader digital transformation of dentistry. The company reports a presence in more than 100 markets worldwide, with Invisalign used by millions of patients and a large installed base of trained doctors, reflecting both scale and brand strength. From a competitive standpoint, Align remains one of the most recognizable names in clear aligners and has built a strong moat through brand equity, clinical workflow integration, and an ecosystem approach. Its key products include Invisalign, ClinCheck treatment planning software, iTero Lumina scanners, and exocad software. The strategic logic is to expand from orthodontics into adjacent restorative and multidisciplinary workflows, capturing more of the dental chair-side and lab-side value chain. That is important because competition in aligners can be intense, but Align’s integrated hardware-software-platform model differentiates it from more narrowly focused peers. Recent developments reinforce this positioning. In early February 2026, Align reported fourth-quarter and full-year 2025 results, highlighting better-than-expected revenue trends and improved profitability versus the prior year. The company also reiterated its 2026 outlook and announced a new share repurchase plan, underscoring continued confidence in cash generation. In spring 2026, Align showcased new Invisalign and iTero innovations at the AAO Annual Session, while management also flagged macro uncertainty, including tariff-related and demand-related risks. For investors, ALGN therefore offers a blend of category leadership, international exposure, and ongoing investment in digital dentistry innovation.